Loading…
Synthetic molecules for disruption of the MYC protein-protein interface
[Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein lev...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2018-08, Vol.26 (14), p.4234-4239 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3 |
container_end_page | 4239 |
container_issue | 14 |
container_start_page | 4234 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 26 |
creator | Jacob, Nicholas T. Miranda, Pedro O. Shirey, Ryan J. Gautam, Ritika Zhou, Bin de Orbe Izquierdo, M. Elena Hixon, Mark S. Hart, Jonathan R. Ueno, Lynn Vogt, Peter K. Janda, Kim D. |
description | [Display omitted]
MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology. |
doi_str_mv | 10.1016/j.bmc.2018.07.019 |
format | article |
fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089618310319</els_id><sourcerecordid>S0968089618310319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRbK1-AC-SL5A4k81fBEGKVqHiQT14Wja7E7slyZZNWui3d0ur6MXTG5j33jA_xi4RIgTMrpdR1aooBiwiyCPA8oiNMcmSkPMSj9kYyqwIoSizETvr-yUAxEmJp2zEAXiep3zMZq_bbljQYFTQ2obUuqE-qK0LtOndejUY2wW2DrwleP6YBitnBzJdeNDAdAO5Wio6Zye1bHq6OOiEvT_cv00fw_nL7Gl6Nw9VkuIQ1jpVRUZxrBMJGIOfsEor5LUuFZbca8xjmVGqcsg1z0vIpEyQU52rSms-Ybf73tW6akkr6gYnG7FyppVuK6w04u-mMwvxaTciizFJgPsC3BcoZ_veUf2TRRA7qmIpPFWxoyogF56qz1z9PvqT-MboDTd7A_nXN4ac6JWhTpE2jtQgtDX_1H8BK-aKIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><source>ScienceDirect Journals</source><creator>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</creator><creatorcontrib>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</creatorcontrib><description>[Display omitted]
MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2018.07.019</identifier><identifier>PMID: 30037753</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Dose-Response Relationship, Drug ; Humans ; Hydrophobic and Hydrophilic Interactions ; Molecular Structure ; Protein Binding - drug effects ; Proto-Oncogene Proteins c-myc - antagonists & inhibitors ; Proto-Oncogene Proteins c-myc - metabolism ; Pyridines - chemical synthesis ; Pyridines - chemistry ; Pyridines - pharmacology ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Solubility ; Structure-Activity Relationship ; Surface Plasmon Resonance</subject><ispartof>Bioorganic & medicinal chemistry, 2018-08, Vol.26 (14), p.4234-4239</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</citedby><cites>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</cites><orcidid>0000-0002-2064-9160</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30037753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacob, Nicholas T.</creatorcontrib><creatorcontrib>Miranda, Pedro O.</creatorcontrib><creatorcontrib>Shirey, Ryan J.</creatorcontrib><creatorcontrib>Gautam, Ritika</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>de Orbe Izquierdo, M. Elena</creatorcontrib><creatorcontrib>Hixon, Mark S.</creatorcontrib><creatorcontrib>Hart, Jonathan R.</creatorcontrib><creatorcontrib>Ueno, Lynn</creatorcontrib><creatorcontrib>Vogt, Peter K.</creatorcontrib><creatorcontrib>Janda, Kim D.</creatorcontrib><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted]
MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</description><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Molecular Structure</subject><subject>Protein Binding - drug effects</subject><subject>Proto-Oncogene Proteins c-myc - antagonists & inhibitors</subject><subject>Proto-Oncogene Proteins c-myc - metabolism</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - pharmacology</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Solubility</subject><subject>Structure-Activity Relationship</subject><subject>Surface Plasmon Resonance</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE9Lw0AQxRdRbK1-AC-SL5A4k81fBEGKVqHiQT14Wja7E7slyZZNWui3d0ur6MXTG5j33jA_xi4RIgTMrpdR1aooBiwiyCPA8oiNMcmSkPMSj9kYyqwIoSizETvr-yUAxEmJp2zEAXiep3zMZq_bbljQYFTQ2obUuqE-qK0LtOndejUY2wW2DrwleP6YBitnBzJdeNDAdAO5Wio6Zye1bHq6OOiEvT_cv00fw_nL7Gl6Nw9VkuIQ1jpVRUZxrBMJGIOfsEor5LUuFZbca8xjmVGqcsg1z0vIpEyQU52rSms-Ybf73tW6akkr6gYnG7FyppVuK6w04u-mMwvxaTciizFJgPsC3BcoZ_veUf2TRRA7qmIpPFWxoyogF56qz1z9PvqT-MboDTd7A_nXN4ac6JWhTpE2jtQgtDX_1H8BK-aKIA</recordid><startdate>20180807</startdate><enddate>20180807</enddate><creator>Jacob, Nicholas T.</creator><creator>Miranda, Pedro O.</creator><creator>Shirey, Ryan J.</creator><creator>Gautam, Ritika</creator><creator>Zhou, Bin</creator><creator>de Orbe Izquierdo, M. Elena</creator><creator>Hixon, Mark S.</creator><creator>Hart, Jonathan R.</creator><creator>Ueno, Lynn</creator><creator>Vogt, Peter K.</creator><creator>Janda, Kim D.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2064-9160</orcidid></search><sort><creationdate>20180807</creationdate><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><author>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Molecular Structure</topic><topic>Protein Binding - drug effects</topic><topic>Proto-Oncogene Proteins c-myc - antagonists & inhibitors</topic><topic>Proto-Oncogene Proteins c-myc - metabolism</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - pharmacology</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Solubility</topic><topic>Structure-Activity Relationship</topic><topic>Surface Plasmon Resonance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacob, Nicholas T.</creatorcontrib><creatorcontrib>Miranda, Pedro O.</creatorcontrib><creatorcontrib>Shirey, Ryan J.</creatorcontrib><creatorcontrib>Gautam, Ritika</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>de Orbe Izquierdo, M. Elena</creatorcontrib><creatorcontrib>Hixon, Mark S.</creatorcontrib><creatorcontrib>Hart, Jonathan R.</creatorcontrib><creatorcontrib>Ueno, Lynn</creatorcontrib><creatorcontrib>Vogt, Peter K.</creatorcontrib><creatorcontrib>Janda, Kim D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacob, Nicholas T.</au><au>Miranda, Pedro O.</au><au>Shirey, Ryan J.</au><au>Gautam, Ritika</au><au>Zhou, Bin</au><au>de Orbe Izquierdo, M. Elena</au><au>Hixon, Mark S.</au><au>Hart, Jonathan R.</au><au>Ueno, Lynn</au><au>Vogt, Peter K.</au><au>Janda, Kim D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthetic molecules for disruption of the MYC protein-protein interface</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2018-08-07</date><risdate>2018</risdate><volume>26</volume><issue>14</issue><spage>4234</spage><epage>4239</epage><pages>4234-4239</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted]
MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30037753</pmid><doi>10.1016/j.bmc.2018.07.019</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-2064-9160</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2018-08, Vol.26 (14), p.4234-4239 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214403 |
source | ScienceDirect Journals |
subjects | Dose-Response Relationship, Drug Humans Hydrophobic and Hydrophilic Interactions Molecular Structure Protein Binding - drug effects Proto-Oncogene Proteins c-myc - antagonists & inhibitors Proto-Oncogene Proteins c-myc - metabolism Pyridines - chemical synthesis Pyridines - chemistry Pyridines - pharmacology Pyrimidines - chemical synthesis Pyrimidines - chemistry Pyrimidines - pharmacology Solubility Structure-Activity Relationship Surface Plasmon Resonance |
title | Synthetic molecules for disruption of the MYC protein-protein interface |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthetic%20molecules%20for%20disruption%20of%20the%20MYC%20protein-protein%20interface&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Jacob,%20Nicholas%20T.&rft.date=2018-08-07&rft.volume=26&rft.issue=14&rft.spage=4234&rft.epage=4239&rft.pages=4234-4239&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2018.07.019&rft_dat=%3Celsevier_pubme%3ES0968089618310319%3C/elsevier_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30037753&rfr_iscdi=true |